Total synthesis of (±)-methyl-kinamycin C

Tetrahedron

Volumn 63, Issue 24, 2007, Pages 5189-5199

  Kumamoto, Takuya ^a   Kitani, Yasuo ^a   Tsuchiya, Hideyoshi ^a   Yamaguchi, Kentaro ^b   Seki, Hiroko ^a   Ishikawa, Tsutomu ^a  

^a CHIBA UNIVERSITY   (Japan)

^b TOKUSHIMA BUNRI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,4,4A PENTAHYDROXY 6,7,11 TRIMETHOXY 3 METHYL 1,2,3,4,4A,11B HEXAHYDROXYBENZO[B]FLUOREN 5 ONE; 1,3,4,4A TETRAHYDROXY 6,7,11 TRIMETHOXY 3 METHYL 3,4,4A,11B TETRAHYDRO 1H BENZO[B]FLUORENE 2,5 DIONE; 1,4A DIHYDROXY 6,7,11 TRIMETHOXY 3 METHYL 4A,11B DIHYDRO 1H BENZO[B]FLUORENE 5 DIONE; 2 HYDROXY 3 METHYL 1,3,4,4A TETRAKIS(TRIMETHYLSILANYLOXY) 6,7 11 TRIMETHOXY 1,2,3,4,4A,11B HEXAHYDROBENZO[B]FLUOREN 11 ONE; 2,4 DIACETOXY 3 HYDROXY 6,7,11 TRIMETHOXY 3 METHYL 5 (4 TOLUENESULFONYLHYDRAZONO) 2,3,4,5 TETRAHYDRO 1H BENZO[B]FLUOREN 1 YL ACETIC ACID; 2,4 DIACETOXY 3 HYDROXY 6,7,11 TRIMETHOXY 3 METHYL 5 OXO 2,3,4,5 TETRAHYDRO 1H BENZO[B]FLUOREN 1 YL ACETIC ACID; 2,4 DIACETOXY 3,4 DIHYDROXY 6,7,11 TRIMETHOXY 3 METHYL 5 OXO 2,3,4,4A,5,11B HEXAHYDRO 1H BENZO[B]FLUOREN 1 YL ACETATE; 2,4 DIACETOXY 3,4A BIS(METHYLSULFANYLTHIOCARBOXYOXY) 6,7,11 TRIMETHOXY 3 METHYL 5 OXO 2,3,4,4A,5,11B HEXAHYDRO 1H BENZO[B]FLUOREN 1 YL ACETATE; 2,4 DIACETOXY 6,7,11 TRIMETHOXY 3 METHYL 3 METHYLSULFANYL 5 OXO 2,3,4,5,TETRAHYDRO 1H BENZO[B]FLUOREN 1 YL ACETATE; 2,4 DIACETOXY 6,7,11 TRIMETHOXY 3 METHYL 5 OXO 1 SULFAMYLOXY 2,3,4,11,TETRAHYDRO 1H BENZO[B]FLUOREN 1 YL ACETATE; 3 METHYL 6,7,11 TRIMETHOXY 1,2,3,4,4A,11B HEXAHYDROXYBENZO[B]FLUORENE 1,2,3,4,4A,11B HEXAOL; 3,4,4A TRIHYDROXY 6,7,11 TRIMETHOXY 3 METHYL 3,4,4A,11B TETRAHYDRO 1H BENZO[B]FLUORENE 2,5 DIONE; 3,4A DIHYDROXY 6,7,11 TRIMETHOXY 3 METHYL 2,5 DIOXO 3,4,4A,11B TETRAHYDRO 1H BENZO[B]FLUOREN 1 YL ACETATE; 4 ACETOXY 2,3 (DIMETHYLMETHYLENEDIOXY) 6,7,11 TRIMETHOXY 3 METHYL 5 OXO 2,3,4,4A,5 TETRAHYDRO 1H BENZO[B]FLUOREN 1 YL ACETIC ACID; 4 ACETOXY 2,3 DIMETHYLMETHYLENEDIOXY 4A HYDROXY 6,7,11 TRIMETHOXY 3 METHYL 5 OXO 2,3,4,4A,5,11B HEXAHYDRO 1H BENZO[B]FLUOREN 1 YL ACETIC ACID; 4 ACETOXY 2,3,4A TRIHYDROXY 6,7,11 TRIMETHOXY 3 METHYL 5 OXO 2,3,4,4A,5,11B HEXAHYDRO 1H BENZO[B]FLUOREN 1 YL ACETIC ACID; 4 ACETOXY 3,4A DIHYDROXY 6,7,11 TRIMETHOXY 3 METHYL 2,5 DIOXO 2,3,4,4A,5,11B HEXAHYDRO 1H BENZO[B]FLUOREN 1 YL ACETIC ACID; 6,7,11 TRIMETHOXY 3 METHYL 1,2,5,11B TETRAHYDROXYBENZO[B]FLUORENE 1,2,4A,5 TETRAOL; 6,7,11 TRIMETHOXY 3 METHYL 1,3,4,4A TETRAKIS(TRIMETHYLSILANYLOXY) 3,4,4A,11B TETRAHYDRO 1H BENZO[B]FLUORENE 2,5 DIONE; 6,7,11 TRIMETHOXY 3 METHYL 1,4A BIS(TRIMETHYLSILANYLOXY) 4A,11B DIHYDROXYBENZO[B]FLUORENE 5 ONE; 6,7,11 TRIMETHOXY 3 METHYL 2,3,4,4A TETRAKIS(TRIMETHYLSILANYLOXY) 3,4,4A,11B TETRAHYDROXYBENZO[B]FLUOREN 5 ONE; ALKADIENE; BENZINDENONE; KINAMYCIN; METHYL KINAMYCIN C; UNCLASSIFIED DRUG;

ARTICLE; CRYSTAL STRUCTURE; DIELS ALDER REACTION; DRUG STRUCTURE; DRUG SYNTHESIS; PRIORITY JOURNAL; STEREOCHEMISTRY;

ALNUS;

EID: 34248183653     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2007.03.166     Document Type: Article

References (43)

1. For reviews, see:
2. Gould S.J. Chem. Rev. 97 (1997) 2499-2509
3. Marco-Contelles J., and Molina M.T. Curr. Org. Chem. 7 (2003) 1433-1442
4. Kumamoto T., Ishikawa T., and Ōmura S. J. Synth. Org. Chem. Jpn. 62 (2004) 49-58
5. Itō S., Matsuya T., Ōmura S., Otani M., Nakagawa A., Takeshima H., Iwai Y., Ohtani M., and Hata T. J. Antibiot. 23 (1970) 315-317
6. Hata T., Ōmura S., Iwai Y., Nakagawa A., Otani M., Itō S., and Matsuya T. J. Antibiot. 24 (1971) 353-359
7. Feldman K.S., and Eastman K.J. J. Am. Chem. Soc. 128 (2006) 12562-12573
8. Hasinoff B.B., Wu X., Yalowich J.C., Goodfellow V., Laufer R.S., Adedayo O., and Dmitrienko G.I. Anticancer Drugs 17 (2006) 825-837
9. Ōmura S., Nakagawa A., Yamada H., Hata T., Furusaki A., and Watanabe T. Chem. Pharm. Bull. 19 (1971) 2428-2430
10. Ōmura S., Nakagawa A., Yamada H., Hata T., Furusaki A., and Watanabe T. Chem. Pharm. Bull. 21 (1973) 931-940
11. Furusaki A., Matsui M., Watanabé T., Ōmura S., Nakagawa A., and Hata T. Isr. J. Chem. 10 (1972) 173-187
12. Seaton P.J., and Gould S.J. J. Antibiot. 42 (1989) 189-197
13. -1. See: Ref. 4.
14. Echavarren A.M., Tamayo N., and Parades M.C. Tetrahedron Lett. 34 (1993) 4713-4716
15. Gould S.J., Tamayo N., Melville C.R., and Cone M.C. J. Am. Chem. Soc. 116 (1994) 2207-2208
16. Mithani S., Weeratunga G., Taylor N., and Dmitrienko G.I. J. Am. Chem. Soc. 116 (1994) 2209-2210
17. Hauser F.M., and Zhou M. J. Org. Chem. 61 (1996) 5722
18. Proteau P.J., Li Y., Chen J., Williamson R.T., Gould S.J., Laufer R.S., and Dmitrienko G.I. J. Am. Chem. Soc. 122 (2000) 8325-8326
19. The terms prekinamycin and isoprekinamycin are now applied to the structures 4 and 5, respectively, because Gould reported the isolation of 4 as another metabolite produced by S. murayamaensis (. Gould S.J., Chen J., Cone M.C., Gore M.P., Melville C.R., and Tamayo N. J. Org. Chem. 61 (1996) 5720-5721 )
20. He H., Ding W.-D., Bernan V.S., Richardson A.D., Ireland C.M., Greenstein M., Ellestad G.A., and Carter G.T. J. Am. Chem. Soc. 123 (2001) 5362-5363
21. 13C NMR. Seaton P.J., and Gould S.J. J. Am. Chem. Soc. 110 (1988) 5912-5914
22. Lei X., and Porco Jr. J.A. J. Am. Chem. Soc. 128 (2006) 14790-14791
23. Kumamoto T., Tabe N., Yamaguchi K., and Ishikawa T. Tetrahedron Lett. 41 (2000) 5693-5697
24. Kumamoto T., Tabe N., Yamaguchi K., Yagishita H., Iwasa H., and Ishikawa T. Tetrahedron 57 (2001) 2717-2728
25. Kitani Y., Morita A., Kumamoto T., and Ishikawa T. Helv. Chim. Acta 85 (2002) 1186-1195
26. The structure of 14 was deduced by comparison of spectral data with that of by-product obtained in model system (Kumamoto, T.; Ishikawa, T. Unpublished result). The detail will be reported elsewhere.
27. Rubottom G.M., and Gruber J.M. J. Org. Chem. 43 (1978) 1599-1602
28. Donohoe T.J., Blades K., Moore P.R., Waring M.J., Winter J.J.G., Helliwell M., Newcomb N.J., and Stemp G. J. Org. Chem. 67 (2002) 7946-7956
29. * in Figure 3 were observed, but the intensities were observed over 50% for several times.
30. Modified procedure of Hurst et al. Hurst D.T., and McInnes A.G. Can. J. Chem. 43 (1965) 2004-2011
31. Nakata T., Tanaka T., and Oishi T. Tetrahedron Lett. 24 (1983) 2653-2656
32. 2)=0.0999. CCDC 638781.
33. Evans D.A., Chapman K.T., and Carreira E.M. J. Am. Chem. Soc. 110 (1988) 3560-3578
34. 2)=0.1362. CCDC 618952.
35. Displacement of benzylic xanthate to methylthio group in thermal condition was reported:
36. Eto M., Nishimoto M., Ueshima T., Hisano T., and Harano K. J. Chem. Soc., Perkin Trans. 2 (1995) 1155-1162
37. Kryczka B., and Descotes G. Bull. Pol. Acad. Sci. Chem. 33 (1985) 475-482
38. Burgess E.M., Penton Jr. H.R., and Taylor E.A. J. Am. Chem. Soc. 92 (1970) 5224-5226
39. 3 via five-membered ring transition state for the synthesis of rocaglaols:
40. Diedrichs N., Ragot J.P., and Thede K. Eur. J. Org. Chem. (2005) 1731-1735
41. Dobler M.R., Bruce I., Cederbaum F., Cooke N.G., Diorazio L.J., Hall R.G., and Irving E. Tetrahedron Lett. 42 (2001) 8281-8284
42. Ketal formation in 4-cyclohexene-trans-1,2-diol system has already been reported in the derivatization of kinamycins: see, Ref. 4b.
43. Abad A., Arnó A.M., Domingo L.R., and Zaragozá R.J. J. Org. Chem. 53 (1988) 3761-3772